Latvian pharmaceutical manufacturing company Grindeks recently announced it opened 28 new subsidiaries in Europe to develop new products. Grindeks provides a full product lifecycle, including research, development, pharmacovigilance, manufacturing, and sales of original products, generic drugs and active pharmaceutical ingredients. It specializes in cardiology, central nervous system, oncology, diabetes and dermatology. With the new expanded…